Matches in Wikidata for { <http://www.wikidata.org/entity/Q37208194> ?p ?o ?g. }
- Q37208194 description "article científic" @default.
- Q37208194 description "article scientifique" @default.
- Q37208194 description "articolo scientifico" @default.
- Q37208194 description "artigo científico" @default.
- Q37208194 description "artículu científicu espublizáu en 2015" @default.
- Q37208194 description "bilimsel makale" @default.
- Q37208194 description "scientific article published on 09 September 2015" @default.
- Q37208194 description "vedecký článok" @default.
- Q37208194 description "vetenskaplig artikel" @default.
- Q37208194 description "videnskabelig artikel" @default.
- Q37208194 description "vědecký článek" @default.
- Q37208194 description "wetenschappelijk artikel" @default.
- Q37208194 description "wissenschaftlicher Artikel" @default.
- Q37208194 description "наукова стаття, опублікована у вересні 2015" @default.
- Q37208194 description "научни чланак" @default.
- Q37208194 description "مقالة علمية نشرت في 09 سبتمبر 2015" @default.
- Q37208194 name "Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer" @default.
- Q37208194 name "Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer" @default.
- Q37208194 name "Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer" @default.
- Q37208194 type Item @default.
- Q37208194 label "Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer" @default.
- Q37208194 label "Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer" @default.
- Q37208194 label "Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer" @default.
- Q37208194 prefLabel "Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer" @default.
- Q37208194 prefLabel "Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer" @default.
- Q37208194 prefLabel "Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer" @default.
- Q37208194 P1433 Q37208194-5B5F6F10-0A6A-4A17-B78D-FB8EFC3692CB @default.
- Q37208194 P1476 Q37208194-BA4B81B2-6811-4878-8E29-A4CF14550465 @default.
- Q37208194 P2093 Q37208194-2A5772DB-A609-46BA-BD2F-9FB013D29C0F @default.
- Q37208194 P2093 Q37208194-3FBB9421-0E8D-4613-884E-1C2E5513B034 @default.
- Q37208194 P2093 Q37208194-5345B97D-F468-4EFB-BA7F-CF70AB11F9D4 @default.
- Q37208194 P2093 Q37208194-6639C6E9-B228-49A0-96C8-E15E3825DBAD @default.
- Q37208194 P2093 Q37208194-8DBE10A9-74AD-4E45-8E2A-04658931F2F9 @default.
- Q37208194 P2093 Q37208194-91526830-E110-4566-8901-97B3FF500F06 @default.
- Q37208194 P2093 Q37208194-C181BE43-894A-4C99-B189-F46510CB0287 @default.
- Q37208194 P2093 Q37208194-C6648598-2107-4CC7-AECB-258DB1D1B906 @default.
- Q37208194 P2093 Q37208194-E54F8261-D599-43AF-9837-EC65F383F1FF @default.
- Q37208194 P2093 Q37208194-EE33ACFB-97BA-4D32-BE09-8B459247824F @default.
- Q37208194 P2093 Q37208194-F21A5433-7647-4B91-ABEA-44C0A9567B6D @default.
- Q37208194 P275 Q37208194-28bb4bea-7f8a-4fae-96a5-23cd0b3c9f4b @default.
- Q37208194 P2860 Q37208194-13A1C986-9FEF-404D-A93B-1E309333C589 @default.
- Q37208194 P2860 Q37208194-1667BCCA-88EF-462F-9DB3-60367050953E @default.
- Q37208194 P2860 Q37208194-4C427D69-F6C8-464E-852B-0E48FB87B6CA @default.
- Q37208194 P2860 Q37208194-4E50FF86-63D8-47B6-8808-270341CD8A9E @default.
- Q37208194 P2860 Q37208194-5056E5D9-DB5F-4178-AB08-594C687E97DD @default.
- Q37208194 P2860 Q37208194-751542F9-2B3D-4A03-828D-3D281DF4C3F6 @default.
- Q37208194 P2860 Q37208194-7970D3E9-17E1-4E5E-9F18-3D6AB2AD6415 @default.
- Q37208194 P2860 Q37208194-801C06E5-5408-480C-9B5A-49A60CEAC5CD @default.
- Q37208194 P2860 Q37208194-87631358-33F1-4673-911F-A38DC3980680 @default.
- Q37208194 P2860 Q37208194-8AB2E567-1AC5-4823-9B6F-32B32100CAD8 @default.
- Q37208194 P2860 Q37208194-9C5924FC-6C86-4D72-833E-0E7F12C8A4F5 @default.
- Q37208194 P2860 Q37208194-A2066D04-F15F-48DC-910F-2AA0CF98BD59 @default.
- Q37208194 P2860 Q37208194-A39800BB-7983-482D-BDC8-41AA9DF6517A @default.
- Q37208194 P2860 Q37208194-A3FBC2AD-1152-4F3D-AC18-C254DAEBA782 @default.
- Q37208194 P2860 Q37208194-BAAB1510-DB61-4F17-91C4-88AA5C546671 @default.
- Q37208194 P2860 Q37208194-C84D9262-DC1C-40CB-A814-D6FC050AAEFC @default.
- Q37208194 P2860 Q37208194-F789C54B-6FAA-4BC9-BE7F-1F7406AA74CE @default.
- Q37208194 P2888 Q37208194-08D05833-BA05-4B84-AF27-0918E28A4834 @default.
- Q37208194 P304 Q37208194-EEB62EA5-BBA2-4C49-B3A9-52AAFDC72BD1 @default.
- Q37208194 P31 Q37208194-F4BC76B3-051A-426C-981F-B78EC0D9DA36 @default.
- Q37208194 P356 Q37208194-6B295B33-9742-4925-AC0E-637B125BA62F @default.
- Q37208194 P433 Q37208194-DA5B0DB0-C1E4-4C6F-8CEB-562CF997A97B @default.
- Q37208194 P478 Q37208194-67F740F9-0E16-4454-9B86-0A007140B748 @default.
- Q37208194 P577 Q37208194-96AB0404-7781-42E2-8F79-89BFB171AA1B @default.
- Q37208194 P5875 Q37208194-663FE290-7319-4557-880F-332944D91A57 @default.
- Q37208194 P6216 Q37208194-271fcf98-8e7f-478e-80ea-159ac59ed7d7 @default.
- Q37208194 P698 Q37208194-7FB88700-570A-456F-AEFE-C0B84DE6B7DD @default.
- Q37208194 P932 Q37208194-62B778CB-8E91-4225-A39B-A604CF12FE8E @default.
- Q37208194 P356 S12282-015-0637-4 @default.
- Q37208194 P698 26350351 @default.
- Q37208194 P1433 Q15752871 @default.
- Q37208194 P1476 "Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer" @default.
- Q37208194 P2093 "Anita Jesena" @default.
- Q37208194 P2093 "Eisei Shin" @default.
- Q37208194 P2093 "Hee Jeong Kim" @default.
- Q37208194 P2093 "Hwei-Chung Wang" @default.
- Q37208194 P2093 "Jofel Isidro" @default.
- Q37208194 P2093 "Ku Sang Kim" @default.
- Q37208194 P2093 "Nobuaki Sato" @default.
- Q37208194 P2093 "Santi Lokejaroenlarb" @default.
- Q37208194 P2093 "Shinzaburo Noguchi" @default.
- Q37208194 P2093 "Vani Parmar" @default.
- Q37208194 P2093 "Yohji Itoh" @default.
- Q37208194 P275 Q20007257 @default.
- Q37208194 P2860 Q28131668 @default.
- Q37208194 P2860 Q30317067 @default.
- Q37208194 P2860 Q32034037 @default.
- Q37208194 P2860 Q34421634 @default.
- Q37208194 P2860 Q34565485 @default.
- Q37208194 P2860 Q44253498 @default.
- Q37208194 P2860 Q44253501 @default.
- Q37208194 P2860 Q44265649 @default.
- Q37208194 P2860 Q46663084 @default.
- Q37208194 P2860 Q50994426 @default.
- Q37208194 P2860 Q54031458 @default.
- Q37208194 P2860 Q59289367 @default.
- Q37208194 P2860 Q72209740 @default.
- Q37208194 P2860 Q72221592 @default.
- Q37208194 P2860 Q73862163 @default.
- Q37208194 P2860 Q74329724 @default.